The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 ImmunoGen Inc.  (IMGN) Trade Now »     Rate IMGN  -  Discuss IMGN  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
60.0%
Top:
100.0%
Rate IMGN:



IMGN Analysis & Videos »


IMGN: Bull or Bear?

Immunogen (IMGN): Investing in antibody technology Graphic_rating_buy IMGN
-6.29%
in 131 days

Filed under: Newsletters, Genentech Inc (DNA), Stocks to Buy

"How does one go about investing in the antibody space?" asks biotech specialist John McCamant. In The Medical Technology Stock Letter, he eyes Immunogen (NASDAQ: IMGN), and offers an in-depth report for biotech-savvy readers.

"As background, T-DM1 is a second generation Herceptin that may even exceed the original in sales because the armed antibody has been more potent to date by showing effectiveness in mBC patients who have failed either Herceptin or Tykerb.

<>"The company will continue to benefit from Genetech's extensive antibody ...
By  Steven Halpern   (+4.73%  risk: moderate)  07/14/09 Comment


FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO Graphic_rating_buy IMGN
Mikerun
73%
 -3.02%
in 175 days
<> Below is a summary of updates to the BioMedReports.com database of over 200 entries included in the <font> FDA and Clinical Trial Calendars </font> . The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision deadline dates while the Clinical Trial Calendar encompasses pending clinical trial results (with a focus on late-stage, Phase 3 trials), pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), and pending re-submissions to the FDA for complete respon...
By  Mike Havrilla   (+1.04%  risk: conservative)  05/31/09 Comment


Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches Graphic_rating_buy IMGN
Mikerun
73%
 +17.76%
in 14 days
(closed on 05/31/09)
<> Below is a summary of updates to the <font> BioMedReports.com </font> database of over 200 entries included in the <font> FDA and Clinical Trial Calendars </font> . The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision deadline dates while the Clinical Trial Calendar encompasses pending clinical trial results (with a focus on late-stage, Phase 3 trials), pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), and pending re-submissions to the FDA fo...
By  Mike Havrilla   (+1.04%  risk: conservative)  05/17/09 Comment


Get free stock alert for IMGN:
Your Email Address:


Bullish on IMGN ... Graphic_rating_buy IMGN
Foto
62%
 +19.11%
in 236 days
ImmunoGen, Inc. engages in the research and development of antibody-based anticancer therapeutics in the United States. The company develops therapeutics for the treatment of cancer using its Tumor-Activated Prodrug (TAP) technology, which uses antibodies to deliver a potent cytotoxic agent. Its products include IMGN242, a Phase I clinical trial product for the treatment of CanAg-expressing gastric, pancreatic, and colorectal cancer; and IMGN901, which is in three clinical trials for the treatment of multiple myeloma as well as other hematological malignancies, small-cell lung cancer, ovari...
By  Marian Filo   (-24.55%  risk: aggressive)  03/31/09 Comment





People Bullish on IMGN

Steven Halpern
Tracked Blogger
56%
4 mos ago

Mikerun
Mike Havrilla
Principal
73%
5 mos ago

Foto
Marian Filo
Principal
62%
7 mos ago

Dallas W
Analyst
N/A
over 2 years ago


People Bearish on IMGN

mgs0800
Analyst
25%
about 1 year ago

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.25% 378
2 Gerald Greene 18.14 +70.10% 208
3 stockmarketfunding.com 17.66 +25.70% 55
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +75.30% 38


POPULAR STOCKS
Symbol Company Name Sentiment
AMD Advanced Micro Devices Inc
C Citigroup Inc
XOM Exxon Mobil Corp
KO The CocaCola Company
BAC Bank of America Corp
T AT&T Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on IMGN


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About ImmunoGen Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch